CAR-armored-cell therapy in solid tumor treatment
Journal of Translational Medicine · 28.11.2024 · 22 (1)
DOI: 10.1186/s12967-024-05903-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Translational Medicine, online erschienen am 28.11.2024. Verfasst von Yan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Navy Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Navy Medical University, Shanghai, 200433, China.
- Linyi People's Hospital, Linyi, Shandong, 276000, China.
- National Key Laboratory of Medical Immunology & Institute of Immunology, Naval Medical University, Shanghai, China.
- Navy Medical University, Shanghai, 200433, China. guo918meng@163.com.
- National Key Laboratory of Medical Immunology & Institute of Immunology, Naval Medical University, Shanghai, China. guo918meng@163.com.
- Navy Medical University, Shanghai, 200433, China. luojh@immunol.org.
ORCID-Profile: Jianhua Luo
Zitieren
APA
Liu, Y., Xiao, L., Yang, M., Chen, X., Liu, H., Wang, Q., Guo, M., & Luo, J. (2024). CAR-armored-cell therapy in solid tumor treatment. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05903-3
Vancouver
Liu Y, Xiao L, Yang M, Chen X, Liu H, Wang Q, et al. CAR-armored-cell therapy in solid tumor treatment. Journal of Translational Medicine. 2024;22(1). doi:10.1186/s12967-024-05903-3
BibTeX
@article{Liu2024,
author = {Liu, Yan and Xiao, Lin and Yang, Mingxuan and Chen, Xuemei and Liu, Hongyue and Wang, Quanxing and Guo, Meng and Luo, Jianhua},
title = {CAR-armored-cell therapy in solid tumor treatment},
journal = {Journal of Translational Medicine},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12967-024-05903-3}
}
EUVIMED